Afterload reduction in the management of congestive heart failure following acute myocardial infarction.
D000208:Acute Disease; D004298:Dopamine / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications*; D009566:Nitrates / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D009566:Nitrates; D014665:Vasodilator Agents; D009599:Nitroprusside; D006830:Hydralazine; D004298:Dopamine; D011224:Prazosin